Joseph Domachowske, MD

The evolution of vaccines to protect against invasive meningococcal infection has finally allowed availability and potential to protect against each of the five major serogroups.

Despite excellent DTaP coverage rates in children and Tdap coverage rates in adolescents, survey data suggest that only about 17% of adults have ever received a Tdap booster dose.